Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 457971, 11 pages
http://dx.doi.org/10.1155/2013/457971
Research Article

Hyperglycemia Induces Altered Expressions of Angiogenesis Associated Molecules in the Trophoblast

1Graduate Institute of Biomedical Materials and Tissue Engineering, College of Oral Medicine, Taipei Medical University, 250 Wu-Hsin Street, Taipei 110, Taiwan
2The Ph.D. Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, 250 Wu-Hsin Street, Taipei 110, Taiwan
3Center for Reproductive Medicine, Taipei Medical University Hospital, 252 Wu-Hsin Street, Taipei 110, Taiwan
4Center for Translational Medicine, Taipei Medical University, 250 Wu-Hsin Street, Taipei 110, Taiwan

Received 9 April 2013; Revised 26 June 2013; Accepted 29 June 2013

Academic Editor: Wen-Chin Yang

Copyright © 2013 Shu-Chun Chang and Wei-Chung Vivian Yang. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Leach, “Placental vascular dysfunction in diabetic pregnancies: intimations of fetal cardiovascular disease?” Microcirculation, vol. 18, no. 4, pp. 263–269, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. A. M. Ferreira, B. J. Rollins, D. E. Faunce, A. L. Burns, X. Zhu, and L. A. Dipietro, “The effect of MCP-1 depletion on chemokine and chemokine-related gene expression: evidence for a complex network in acute inflammation,” Cytokine, vol. 30, no. 2, pp. 64–71, 2005. View at Google Scholar
  3. E. Gustafsson, M. Almonte-Becerril, W. Bloch, and M. Costell, “Perlecan maintains microvessel integrity in vivo and modulates their formation in vitro,” PLoS One, vol. 8, no. 1, Article ID e53715, 2013. View at Google Scholar
  4. D. Aviezer, D. Hecht, M. Safran, M. Elsinger, G. David, and A. Yayon, “Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis,” Cell, vol. 79, no. 6, pp. 1005–1013, 1994. View at Google Scholar · View at Scopus
  5. O. Saksela, D. Moscatelli, A. Sommer, and D. B. Rifkin, “Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation,” Journal of Cell Biology, vol. 107, no. 2, pp. 743–751, 1988. View at Google Scholar · View at Scopus
  6. D. D. Carson, M. M. DeSouza, and E. G. C. Regisford, “Mucin and proteoglycan functions in embryo implantation,” BioEssays, vol. 20, no. 7, pp. 577–583, 1998. View at Google Scholar · View at Scopus
  7. N. Raboudi, J. Julian, L. H. Rohde, and D. D. Carson, “Identification of cell-surface heparin/heparan sulfate-binding proteins of a human uterine epithelial cell line (RL95),” Journal of Biological Chemistry, vol. 267, no. 17, pp. 11930–11939, 1992. View at Google Scholar · View at Scopus
  8. S. Liu, S. E. Smith, J. Julian, L. H. Rohde, N. J. Karin, and D. D. Carson, “cDNA cloning and expression of HIP, a novel cell surface heparan sulfate/heparin-binding protein of human uterine epithelial cells and cell lines,” Journal of Biological Chemistry, vol. 271, no. 20, pp. 11817–11823, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. L. H. Rohde, J. Julian, A. Babaknia, and D. D. Carson, “Cell surface expression of HIP, a novel heparin/heparan sulfatebinding protein, of human uterine epithelial cells and cell lines,” Journal of Biological Chemistry, vol. 271, no. 20, pp. 11824–11830, 1996. View at Google Scholar · View at Scopus
  10. W.-C. V. Yang, T.-H. Su, Y.-C. Yang, S.-C. Chang, C.-Y. Chen, and C.-P. Chen, “Altered perlecan expression in placental development and gestational diabetes mellitus,” Placenta, vol. 26, no. 10, pp. 780–788, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. C.-P. Chen, S.-C. Chang, and W.-C. Vivian Yang, “High glucose alters proteoglycan expression and the glycosaminoglycan composition in placentas of women with gestational diabetes mellitus and in cultured trophoblasts,” Placenta, vol. 28, no. 2-3, pp. 97–106, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Huppertz, “The anatomy of the normal placenta,” Journal of Clinical Pathology, vol. 61, no. 12, pp. 1296–1302, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Knofler, “Critical growth factors and signalling pathways controlling human trophoblast invasion,” The International Journal of Developmental Biology, vol. 54, no. 2-3, pp. 269–280, 2010. View at Google Scholar
  14. D.-C. Fischer, H.-D. Haubeck, K. Eich et al., “A novel keratan sulphate domain preferentially expressed on the large aggregating proteoglycan from human articular cartilage is recognized by the monoclonal antibody 3D12/H7,” Biochemical Journal, vol. 318, no. 3, pp. 1051–1056, 1996. View at Google Scholar · View at Scopus
  15. M. H. Doolittle, D. C. Martin, R. C. Davis, M. A. Reuben, and J. Elovson, “A two-cycle immunoprecipitation procedure for reducing nonspecific protein contamination,” Analytical Biochemistry, vol. 195, no. 2, pp. 364–368, 1991. View at Google Scholar · View at Scopus
  16. J. D. Fröhlich, B. Huppertz, P. M. Abuja, J. König, and G. Desoye, “Oxygen modulates the response of first-trimester trophoblasts to hyperglycemia,” American Journal of Pathology, vol. 180, no. 1, pp. 153–164, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Jain, F. W. Logerfo, P. Guthrie, and L. Pradhan, “Effect of hyperglycemia and neuropeptides on interleukin-8 expression and angiogenesis in dermal microvascular endothelial cells,” Journal of Vascular Surgery, vol. 53, no. 6, pp. 1654.e2–1660.e2, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Castorina, S. Giunta, V. Mazzone, V. Cardile, and V. D'Agata, “Effects of PACAP and VIP on hyperglycemia-induced proliferation in murine microvascular endothelial cells,” Peptides, vol. 31, no. 12, pp. 2276–2283, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Duan, L. Paka, and S. Pillarisetti, “Distinct effects of glucose and glucosamine on vascular endothelial and smooth muscle cells: evidence for a protective role for glucosamine in atherosclerosis,” Cardiovascular Diabetology, vol. 4, article 16, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. C. H. Hulme, M. Westwood, J. E. Myers, and A. E. Heazell, “A high-throughput colorimetric-assay for monitoring glucose consumption by cultured trophoblast cells and placental tissue,” Placenta, vol. 33, no. 11, pp. 949–951, 2012. View at Google Scholar
  21. L. Pradhan, C. Nabzdyk, N. D. Andersen, F. W. LoGerfo, and A. Veves, “Inflammation and neuropeptides: the connection in diabetic wound healing,” Expert Reviews in Molecular Medicine, vol. 11, Article ID 2009e2, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Pradhan, X. Cai, S. Wu et al., “Gene expression of pro-inflammatory cytokines and neuropeptides in diabetic wound healing,” Journal of Surgical Research, vol. 167, no. 2, pp. 336–342, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. A. M. Ferreira, B. J. Rollins, D. E. Faunce, A. L. Burns, X. Zhu, and L. A. DiPietro, “The effect of MCP-1 depletion on chemokine and chemokine-related gene expression: evidence for a complex network in acute inflammation,” Cytokine, vol. 30, no. 2, pp. 64–71, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Waehre, M. Vistnes, I. Sjaastad et al., “Chemokines regulate small leucine-rich proteoglycans in the extracellular matrix of the pressure-overloaded right ventricle,” Journal of Applied Physiology, vol. 112, no. 8, pp. 1372–1382, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Herder, T. Illig, J. Baumert et al., “RANTES/CCL5 gene polymorphisms, serum concentrations, and incident type diabetes: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002,” European Journal of Endocrinology, vol. 158, no. 5, pp. R1–R5, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. S. J. Yang, H. B. Iglayreger, H. C. Kadouh, and P. F. Bodary, “Inhibition of the chemokine (C-C motif) ligand 2/chemokine (C-C motif) receptor 2 pathway attenuates hyperglycaemia and inflammation in a mouse model of hepatic steatosis and lipoatrophy,” Diabetologia, vol. 52, no. 5, pp. 972–981, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Liu, D. Hoke, J. Julian, and D. D. Carson, “Heparin/heparan sulfate (HP/HS) interacting protein (HIP) supports cell attachment and selective, high affinity binding of HP/HS,” Journal of Biological Chemistry, vol. 272, no. 41, pp. 25856–25862, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. R. A. Kowluru, “Role of matrix metalloproteinase-9 in the development of diabetic retinopathy and its regulation by H-Ras,” Investigative Ophthalmology and Visual Science, vol. 51, no. 8, pp. 4320–4326, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Zhang, X. Li, and L.-J. Bi, “Alterations of collagen-I, MMP-1 and TIMP-1 in the periodontal ligament of diabetic rats under mechanical stress,” Journal of Periodontal Research, vol. 46, no. 4, pp. 448–455, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Schwenke, M. Knöfler, P. Velicky et al., “Control of human endometrial stromal cell motility by PDGF-BB, HB-EGF and trophoblast-secreted factors,” PLoS One, vol. 8, no. 1, Article ID e54336, 2013. View at Google Scholar
  31. L. Pietro, S. Daher, M. V. C. Rudge et al., “Vascular endothelial growth factor (VEGF) and VEGF-receptor expression in placenta of hyperglycemic pregnant women,” Placenta, vol. 31, no. 9, pp. 770–780, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. Z. Zhou, J. Wang, R. Cao et al., “Impaired angiogenesis, delayed wound healing and retarded tumor growth in Perlecan heparan sulfate-deficient mice,” Cancer Research, vol. 64, no. 14, pp. 4699–4702, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. S. D'Souza, W. Yang, D. Marchetti, C. Muir, M. C. Farach-Carson, and D. D. Carson, “HIP/RPL29 antagonizes VEGF and FGF2 stimulated angiogenesis by interfering with HS-dependent responses,” Journal of Cellular Biochemistry, vol. 105, no. 5, pp. 1183–1193, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. J. M. Whitelock, A. D. Murdoch, R. V. Iozzo, and P. A. Underwood, “The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases,” Journal of Biological Chemistry, vol. 271, no. 17, pp. 10079–10086, 1996. View at Publisher · View at Google Scholar · View at Scopus
  35. C. R. Parish, “Heparan sulfate and inflammation,” Nature Immunology, vol. 6, no. 9, pp. 861–862, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Cooper, G. Tal, O. Lider, and Y. Shaul, “Cytokine induction by the hepatitis B virus capsid in macrophages is facilitated by membrane heparan sulfate and involves TLR2,” Journal of Immunology, vol. 175, no. 5, pp. 3165–3176, 2005. View at Google Scholar · View at Scopus
  37. R. S. Mummery and C. C. Rider, “Characterization of the heparin-binding properties of IL-6,” Journal of Immunology, vol. 165, no. 10, pp. 5671–5679, 2000. View at Google Scholar · View at Scopus
  38. K. R. Taylor and R. L. Gallo, “Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation,” FASEB Journal, vol. 20, no. 1, pp. 9–22, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. A. M. Gori, M. Attanasio, A. Gazzini et al., “Cytokine gene expression and production by human LPS-stimulated mononuclear cells are inhibited by sulfated heparin-like semi-synthetic derivatives,” Journal of Thrombosis and Haemostasis, vol. 2, no. 9, pp. 1657–1662, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. G. M. Campo, A. Avenoso, S. Campo et al., “Purified human plasma glycosaminoglycans reduced NF-κB activation, pro-inflammatory cytokine production and apoptosis in LPS-treated chondrocytes,” Innate Immunity, vol. 14, no. 4, pp. 233–246, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Kuzmicki, B. Telejko, J. Szamatowicz et al., “High resistin and interleukin-6 levels are associated with gestational diabetes mellitus,” Gynecological Endocrinology, vol. 25, no. 4, pp. 258–263, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. M. A. AboElAsrar, N. S. Elbarbary, D. E. Elshennawy, and A. M. Omar, “Insulin-like growth factor-1 cytokines cross-talk in type 1 diabetes mellitus: relationship to microvascular complications and bone mineral density,” Cytokine, vol. 59, no. 1, pp. 86–93, 2012. View at Publisher · View at Google Scholar · View at Scopus